BRIEF—Incyte appoints general manager for Incyte Biosciences UK and Ireland

23 November 2022

US biotech Incyte has appointed Peter Williams as general manager for Incyte Biosciences UK and Ireland.

In his role, Mr Williams will be responsible for the development of medical, regulatory and commercial strategy for Incyte’s portfolio of products in the UK and Ireland.

With over 20 years of pharmaceutical industry experience, Mr Williams is a senior sales and marketing leader with broad experience gained in different commercial functions and senior management roles.

Prior to joining Incyte, he was senior director for sales and marketing at Gilead Sciences UK, and a business unit director at AbbVie UK.

His extensive commercial skills have been demonstrated in the successful creation and development of high performing business units and the launch of several significant new medicines in immunology, hemato-oncology and oncology, Incyte noted.

Companies featured in this story

More ones to watch >